CoChat

Systematic Review: Case-Fatality Rates of Recurrent Venous Thromboembolism and Major Bleeding Events Among Patients Treated for Venous Thromboembolism

Carrier, Marc, Le Gal, Grégoire, Wells, Philip S., Rodger, Marc A. · 2010 · Annals of Internal Medicine

The DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Case-fatality rates are important for assessing the risks and benefits of anticoagulation in patients with venous thromboembolism (VTE). PURPOSE: To summarize case-fatality rates of recurrent VTE and major bleeding events during anticoagulation and recurrent VTE after anticoagulation. DATA SOURCES: MEDLINE, EMBASE, the Cochrane Central Register of Controlled Trials, and all evidence-based medicine reviews in the Ovid interface through the second quarter of 2008. STUDY SELECTION: 69 articles (13 prospective cohort studies and 56 randomized, controlled trials) that reported on patients with symptomatic VTE who received anticoagulation therapy for at least 3 months and on the rate of fatal recurrent VTE and fatal major bleeding. DATA EXTRACTION: Two reviewers independently extracted data onto standardized forms. DATA SYNTHESIS: During the initial 3 months of anticoagulation, the rate of recurrent fatal VTE was 0.4% (95% CI, 0.3% to 0.6%), with a case-fatality rate of 11.3% (CI, 8.0% to 15.2%). The rate of fatal major bleeding events was 0.2% (CI, 0.1% to 0.3%), with a case-fatality rate of 11.3% (CI, 7.5% to 15.9%). After anticoagulation, the rate of fatal recurrent VTE was 0.3 per 100 patient-years (CI, 0.1% to 0.4%), with a case-fatality rate of 3.6% (CI, 1.9% to 5.7%). LIMITATIONS: Estimates come from heterogeneous trial and cohort populations and are not derived from patient-level longitudinal data. Differences in case-fatality rates during and after anticoagulation may be attributable to unmeasured patient characteristics. CONCLUSION: The case-fatality rates of recurrent VTE and major bleeding events are similar during the initial period of VTE treatment. The case-fatality rate of recurrent VTE decreases after completion of the initial period of anticoagulation. When combined with absolute rates of recurrent VTE and major bleeding events, case-fatality rates provide clinicians with a surrogate measure of mortality to balance the risks and benefits of anticoagulant therapy in patients with VTE. PRIMARY FUNDING SOURCE: Canadian Institute for Health Research and Heart and Stroke Foundation of Ontario.

Overview

Integrity signals

Registry

Crossref · 10.7326/0003-4819-152-9-201005040-00008

Cites

85 of 85 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 more claim about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Show all 85 references

Research works printed but not linked: 7

  1. Miller JJ, 1978, The American Statistician, 32, 138
  2. Grau E, 1998, Haematologica, 83, 438
  3. Kirchmaier CM, 1998, Int Angiol, 17, 135
  4. Leroyer C, 1998, Haemostasis, 28, 70
  5. Zidane M, 2006, Haematologica, 91, 1052
  6. van Der Heijden JF, 2000, Cochrane Database Syst Rev, CD002001
  7. van Dongen CJ, 2005, Cochrane Database Syst Rev, CD003074

Cited by

See all 476

Metadata

Authors
Carrier, M., Le Gal, G., Wells, P. S., & Rodger, M. A.
Affiliations
  • University of Ottawa (CA)
  • From University of Ottawa, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada, and Brest University Hospital, Brest, France.
Corresponding author
Carrier, Marc
Venue
Annals of Internal Medicine
Published
2010-05-04
Volume
152
Issue
9
Pages
578-589
ISSN
  • 0003-4819 (ISSN-L)
  • 1539-3704
OpenAlex
W2076621544
Cited by
473
References
85
Citations by year
2026: 10 · 2025: 20 · 2024: 21 · 2023: 16 · 2022: 19 · 2021: 24 · 2020: 37 · 2019: 34 · 2018: 33 · 2017: 48 · 2016: 43 · 2015: 26 · 2014: 30 · 2013: 39 · 2012: 36
FWCI
7.32
Type
journal article
Language
en
Open access
closed
Licence
www.acpjournals.org/journal/aim/text-and-data-mining (tdm)
Locations
  • Annals of Internal Medicine (publishedVersion)
  • PubMed (publishedVersion)
Funders
Canadian Institutes of Health Research
Topics
  • Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
  • Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
Keywords
venous thromboembolism, recurrent venous thromboembolism, case fatality rate, major bleeding, fatal bleeding, anticoagulation, mortality, risk-benefit assessment, anticoagulation duration, pulmonary embolism, deep vein thrombosis, bleeding risk stratification, risk prediction model
MeSH terms
Anticoagulants, Hemorrhage, Humans, Recurrence, Risk Assessment, Venous Thromboembolism

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Systematic Review: Case-Fatality Rates of Recurrent Venous Thromboembolism and Major Bleeding Events Among Patients Treated for Venous Thromboembolism. https://app.cochat.ai/papers/10.7326/0003-4819-152-9-201005040-00008
The paper
Carrier, M., Le Gal, G., Wells, P. S., & Rodger, M. A. (2010). Systematic Review: Case-Fatality Rates of Recurrent Venous Thromboembolism and Major Bleeding Events Among Patients Treated for Venous Thromboembolism. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-152-9-201005040-00008

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.